a. To assess the burden of mumps in the student population.b. To describe the risk factors for mumps virus infection (symptomatic and asymptomatic). c. To determine the relative contribution of household transmission and transmission at the party to…
ID
Source
Brief title
Condition
- Viral infectious disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome of interest is symptomatic mumps.
Secondary outcome
The secondary outcome of interest is mumps virus infection, and the tertiary
outcomes of interest will be mumps related complications (orchitis, meningitis,
pancreatitis) and hospitalisation.
Background summary
Since the beginning of December 2009, the incidence of mumps has increased in
the Netherlands. The majority of cases are among students who have been
vaccinated with at least one dose of MMR vaccine. A review of routine
surveillance data revealed that approximately 30 cases had attended a four-day
student party hosted in a student association building in Leiden, and
implicated the party as the possible source of infection.
Mumps vaccination is included in the Dutch National Immunisation Programme
(Rijksvaccinatieprogramma (RVP)). It is therefore important to investigate
which risk factors play a role in acquisition of mumps virus, and to
characterize this outbreak among vaccinated students. Besides, the 'correlate
for protection' (the immunity level (antibodies or cellular immunity) of an
individual above which he/she is protected against infection) will be
investigated.
Study objective
a. To assess the burden of mumps in the student population.
b. To describe the risk factors for mumps virus infection (symptomatic and
asymptomatic).
c. To determine the relative contribution of household transmission and
transmission at the party to the incidence of symptomatic mumps.
d. To study the contribution of asymptomatic infection to the total number of
mumps virus infections.
Study design
The study is an observational cohort study conducted among students, in which a
questionnaire and samples (oral fluid and finger-prick blood) for
microbiological testing are obtained from participants. The following persons
are eligible to participate: Members of student corpora in Utrecht, Leiden and
Delft who indicated in the pre-screening questionnaire that they could be
contacted for micribiological sampling.
Study burden and risks
The individual participant does not have benefit in participating to this
study. He/she does benefit indirectly since the study aims to improve the
National Immunisation Programme, and it is only a small effort which is needed
from the participants.
Collection of fingerprick blood may be a little painful. The lancet which
pricks the finger is in a plastic protective shield and is sterile. The needle
is not exposed after use of the lancet and cannot be reused. Risk of infecting
another via the lancet is therefore very unlikely.
Postbus 1, postvak 75
3720 BA Bilthoven
NL
Postbus 1, postvak 75
3720 BA Bilthoven
NL
Listed location countries
Age
Inclusion criteria
Members of the Delft, Utrecht and Leiden student corps who have filled in an online questionnaire (pre-screening) and indicated that they agree with additional research.
Exclusion criteria
None
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL33454.041.10 |